A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
Clinical trial NCT04718389 · COMPLETED
Trial details
- NCT number
- NCT04718389
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-26
- Primary completion
- 2025-09-14
- Enrollment
- 1717
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.